Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that its pandemic influenza vaccine for human use Emerflu®*, has been granted marketing authorization from the Australian Therapeutic Goods Administration (TGA).
The details can be read here.
No comments:
Post a Comment